Glioma Cellular Genetics Resource

A collection of cellular models and associated data to underpin the next era of studies into the biology and treatment of glioma.

Image
Glioma-cellular-resource

Glioblastoma is the most common and aggressive form of adult brain cancer and is a strategic priority for Edinburgh Cancer Research. Recurrent genetic and epigenetic perturbations in glioma have now been fully catalogued, but research has been hampered by a lack of open-access and well-annotated patient-derived preclinical models. These will be vital to identify critical therapeutic targets and for use in drug discovery and development.

Cancer Research UK has invested £3.4m in the University of Edinburgh and UCL to enable the generation of these missing research tools and data. Patient-derived glioblastoma cell lines, as well as normal control neural stem cell lines, can be routinely derived in the laboratory and are readily manipulated using CRISPR-based genome editing. Edinburgh has world class expertise in this area.

Our scientists, led by Prof Steven Pollard in Edinburgh, are generating a comprehensive collection of glioblastoma cell lines, control human neural stem cell lines and engineered cell lines with sophisticated genetic and epigenetic disruptions, as well as knock-in reporters for live cell/tumour imaging. These cell lines, and their associated deep molecular annotation (epigenome, transciptome and genome), are available to the global research community through an integrated, open-access Glioma Cellular Genetics Resource (GCGR) web portal.

The GCGR provides much-needed tools to accelerate innovative new science, stimulate UK and international collaborations and support discovery of new therapeutics for glioblastoma.